Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:08.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added site revision tag v3.4.2 and removed the prior funding/status notice (v3.4.1); these are maintenance updates to the site interface and do not affect trial content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T13:57:32.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice added about a lapse in government funding and NIH operating status with links to cc.nih.gov and opm.gov. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T07:54:30.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A glossary toggle was added; metadata labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision is shown as v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:00:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A minor revision update from v3.3.3 to v3.3.4 is shown, with no substantive changes to the page content.
    Difference
    0.0%
    Check dated 2026-01-14T02:28:00.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added location listings for multiple regions (Arkansas, California, Michigan, Missouri, Ontario, Hong Kong, FC, MI, PN, Catalonia) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure link and related location sections.
    Difference
    0.9%
    Check dated 2025-12-23T12:47:09.000Z thumbnail image

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.